From Bench to Bedside: Ensuring Adoption of Clinical Biomarkers
- Understanding drivers and barriers for the adoption of biomarkers
- Sharing J&Js approach to market shaping through agility and partnerships
- Future perspectives on how to manage adoption in the evolving landscape and new CDx modalities, such as AI